UCSF

Tagged: Bioinformatics (Biological and Medical Informatics Graduate Program)

Stopping cancer in its tracks

Cancer, fundamentally, is a problem of too much growth. For decades, health care providers have tried and failed to slow tumor growth using drugs that interfere with a particular signaling pathway, called PI3K, which is known to operate in proliferating cancer cells.

Sali elected to National Academy of Sciences

Andrej Sali, PhD, has been elected as a member of the 2018 class of the National Academy of Sciences (NAS).

Behind enemy lines

New research promises to take the guesswork out of matching individual cancer cases to the most effective choices of chemotherapy.

UCSF School of Pharmacy leads in NIH funding for 38th year

A culture of discovery and collaboration among faculty carries potential to “completely shake up their fields of study.”

Update from the Dean – March 2018

A new PharmD curriculum; Implementing new practice opportunities for pharmacists; PharmD students shine in state and national clinical pharmacy competitions; A pioneer in pharmacogenomics; The NIH streak lives on; Improving adverse event reporting and medication therapy protocols; Big-data to cut...

Babbitt named fellow of the International Society for Computational Biology

Babbitt's election as a 2018 ISCB fellow highlights her contributions to the fields of computational biology and bioinformatics.

UCSF School of Pharmacy joins data-sharing partnership to speed cancer drugs

A pioneering public/private consortium is poised to turn the marathon of drug discovery into a team relay, maybe even a short one.

Computer models speed UCSF scientists toward psychiatric drug discoveries

For decades, scientists have wanted to be able to study dopamine receptors one by one. The brain’s dopamine receptors are responsible for a variety of behaviors, such as reward seeking, and are also involved in psychiatric illnesses like schizophrenia.

Update from the Dean - September 2017

Strategic plan progress report. Research: Driving the development of innovative and precise drugs, medical devices, and diagnostic tests. Flu treatments; Tackling antimalarial resistance; Attacking hard targets; Plotting cell maps; Safer opioid pain killer; Cellular construction; New products...

Pages